Concepedia

Mandy H. van Rhenen

MH

3

Publications

598

Citations

3

H-Index

2019

Active since

Affiliations

University of Tübingen(Current)

Royal Dutch Pharmacists Association

Leiden University Medical Center

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology

Karolinska Institutet

Mandy H. van Rhenen is an author at University of Tübingen specializing in drug discovery, drug safety, and drug resistance.

Top concepts

Publications per year

2019–2023

3

Publications

3

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

, , +9

Development of the <scp>PG</scp>x‐Passport: A Panel of Actionable Germline Genetic Variants for Pre‐Emptive Pharmacogenetic Testing

Cathelijne H. van der Wouden, Mandy H. van Rhenen, Wafa O. M. Jama et al. · Clinical Pharmacology & Therapeutics · 2019 · 96 citations · Full text

Generating evidence for precision medicine: considerations made by the Ubiquitous Pharmacogenomics Consortium when designing and operationalizing the PREPARE study

Cathelijne H. van der Wouden, Stefan Böhringer, Erika Cecchin et al. · Pharmacogenetics and Genomics · 2020 · 40 citations · Full text

Rows per page

1–3 of 3